Results 121 to 130 of about 47,734 (283)

Developing the Inpatient Mental Health Pharmaceutical Assessment and Care Tool (IMPACT) for use by UK mental health pharmacy teams—a modified Delphi study

British Journal of Clinical Pharmacology, Volume 91, Issue 10, Page 2836-2853, October 2025.
Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak, Richard N. Keers, Petra Brown, Penny J. Lewis   +3 more
wiley   +1 more source

Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis [PDF]

, 1992
Elmer Brummer, P R Bhagavathula, L H Hanson, David A. Stevens   +3 more
openalex   +1 more source

High-dose itraconazole in the treatment of severe mycoses [PDF]

, 1991
P. K. Sharkey, Michael G. Rinaldi, James F. Dunn, T C Hardin, Richard J. Fetchick, John R. Graybill   +5 more
openalex   +1 more source

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A. Cornillault, S. Ranque, J. Bonigen, V. Heidelberger, M. Tardieu, A. Maruani, G. Desoubeaux, B. Bonniaud, C. Abasq‐Thomas, J. Pasteur, L. Poujade, C. Chiaverini, J. Miquel, C. Espagnon, A. Perrier, J. V. De Monleon, B. Sterling, J. Flament, A. S. Dussouil, L. Morin, S. Barbarot, A. Dadban, A. Morand, O. Chosidow, B. Guillot, L. Chouchana, R. Cohen, J.‐P. Gangneux, F. Botterel‐Chartier, S. Brun, J. Menotti, A. Folliat, M. A. Richard, S. Mallet, on behalf of Centre de Preuves en Dermatologie de la Société Française de Dermatologie, Groupe de recherche de la Société Française de Dermatologie Pédiatrique, Société Française de Mycologie Médicale, Société Française de Pédiatrie, Société de Pathologie infectieuse de langue française, Groupe Infectiologie Dermatologique et Infections Sexuellement Transmissibles   +39 more
wiley   +1 more source

Treatment of pulmonary aspergilloma with itraconazole. [PDF]

, 1992
Jonathan Burdon, Maree Barnes, Angelique Harris   +2 more
openalex   +1 more source

Anaphylactic Shock Induced by Povidone‐Iodine Vaginal Irrigation During Pregnancy Complicated by Fetal Distress: A Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Anaphylaxis during pregnancy is common, but severe anaphylaxis during pregnancy is relatively rare and may have serious implications for both the mother and the fetus, potentially leading to maternal death or neonatal death. Anaphylaxis caused by iodophor skin disinfection is commonly observed, but there has been no reported case of severe ...
Yanmei Li, Shilin Zhong
wiley   +1 more source

116 NEW ANTIFUNGAL DRUGS IN TEH PRETERM NEONATE: PHARMACOKINETICS OF KETNAZOLE AND ITRACONAZOLE [PDF]

, 1991
John N. van den Anker, M. Koster, J Heijkants, Pieter J.J. Sauer   +3 more
openalex   +1 more source

Lung Resection for Chronic Pulmonary Aspergillosis With an Infected Bulla

Clinical Case Reports, Volume 13, Issue 10, October 2025.
Residual part of the bulla wall (arrow) that was inseparable from the right brachiocephalic vein. ABSTRACT Lung resection for chronic pulmonary aspergillosis with infected bulla may unavoidably leave some infected tissue due to adhesions to the significant vessels and nerves; nevertheless, the treatment strategy of resection for most of the lesion and ...
Kasumi Tamagawa, Shohei Mori, Yu Suyama, Makoto Odaka, Naoki Toya, Takashi Ohtsuka   +5 more
wiley   +1 more source

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib

The Journal of Clinical Pharmacology, Volume 65, Issue 10, Page 1273-1285, October 2025.
Abstract Fruquintinib (FRUZAQLATM) is a highly selective tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3). Two Phase 1, open‐label, single‐dose studies investigated the impact of hepatic or renal impairment on the pharmacokinetics and tolerability of fruquintinib.
Martha Gonzalez, Zhao Yang, William Schelman, Thomas C. Marbury, Juan C. Rondon, William Smith, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +8 more
wiley   +1 more source

PBPK Modeling to Predict Clinical Drug–Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F‐Hydroxypropylamide

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 10, Page 1661-1672, October 2025.
ABSTRACT Upifitamab rilsodotin—an antibody drug conjugate (ADC)—comprises a NaPi2b‐targeted antibody conjugated to an auristatin‐based payload (auristatin F‐hydroxypropylamide [AF‐HPA]). AF‐HPA is metabolized by cytochrome P450 3A4 (CYP3A4) and, to a lower extent, by CYP3A5 and demonstrates both reversible and time‐dependent inhibition of CYP3A4.
Niyanta Kumar, Vaishali Dixit, Howard Burt, Katherine L. Gill, Hannah M. Jones, Natalie Keirstead, Dian Su, Dorin Toader, Timothy B. Lowinger   +8 more
wiley   +1 more source